Vespula pensylvanica isolate Volc-1 chromosome 8, ASM1446617v1, whole genome shotgun sequence.
Vespula pensylvanica (western yellowjacket)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespula.
High-Quality Assemblies for Three Invasive Social Wasps from the Vespula Genus
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM025343.1.\nAssembly name: ASM1446617v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Otago on\n2020/09/09. The original whole-genome shotgun project has the\naccession JACSDY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Otago\nAssembly Date :: 03-JUL-2020\nAssembly Method :: meraculous v. 2.2.6\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 644x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespula pensylvanica Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
ejaculatory bulb-specific protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 296 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cyclin-dependent kinase 10, transcript variant X3
cyclin-dependent kinase 10, transcript variant X2
cyclin-dependent kinase 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X2
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X1
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X1
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X2
intraflagellar transport protein 74 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X9
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X7
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X4
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X8
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X6
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X5
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X1
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X3
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X2
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X10
uncharacterized protein LOC122631194 isoform X1
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
actin cytoskeleton-regulatory complex protein PAN1-like isoform X3
actin cytoskeleton-regulatory complex protein PAN1-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
regulator of G-protein signaling 17, transcript variant X2
regulator of G-protein signaling 17, transcript variant X1
regulator of G-protein signaling 17, transcript variant X3
regulator of G-protein signaling 17, transcript variant X4
regulator of G-protein signaling 17 isoform X1
regulator of G-protein signaling 17 isoform X2
protein grainyhead, transcript variant X1
protein grainyhead, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
serine/threonine-protein kinase greatwall
serine/threonine-protein kinase VRK1-like
nuclear export mediator factor NEMF homolog
lysophospholipid acyltransferase 7, transcript variant X2
lysophospholipid acyltransferase 7, transcript variant X1
serine/arginine-rich splicing factor 2, transcript variant X1
serine/arginine-rich splicing factor 2, transcript variant X2
transcription factor stalky-like, transcript variant X2
transcription factor stalky-like, transcript variant X1
transcription factor stalky-like isoform X2
uncharacterized protein LOC122631266 isoform X1
mediator of RNA polymerase II transcription subunit 7, transcript variant X2
mediator of RNA polymerase II transcription subunit 7, transcript variant X1
mediator of RNA polymerase II transcription subunit 7
tyrosine-protein kinase Btk29A, transcript variant X1
tyrosine-protein kinase Btk29A, transcript variant X2
tyrosine-protein kinase Btk29A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
tyrosine-protein kinase Btk29A isoform X1
tyrosine-protein kinase Btk29A isoform X2
tyrosine-protein kinase Btk29A isoform X3
tyrosine-protein kinase Btk29A, transcript variant X4
tyrosine-protein kinase Btk29A, transcript variant X6
tyrosine-protein kinase Btk29A isoform X4
tyrosine-protein kinase Btk29A, transcript variant X5
tyrosine-protein kinase Btk29A, transcript variant X8
tyrosine-protein kinase Btk29A, transcript variant X7
tyrosine-protein kinase Btk29A isoform X5
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X1
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X5
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X3
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X2
feline leukemia virus subgroup C receptor-related protein 2, transcript variant X4
uncharacterized MFS-type transporter C09D4.1 isoform X1
feline leukemia virus subgroup C receptor-related protein 2 isoform X2
myb-like protein X, transcript variant X1
myb-like protein X, transcript variant X4
myb-like protein X, transcript variant X5
myb-like protein X, transcript variant X6
myb-like protein X, transcript variant X3
uncharacterized protein LOC122631259 isoform X1
uncharacterized protein LOC122631259 isoform X4
uncharacterized protein LOC122631259 isoform X5
myb-like protein X, transcript variant X2
uncharacterized protein LOC122631259 isoform X2
myb-like protein X, transcript variant X7
uncharacterized protein LOC122631259 isoform X7
myb-like protein X, transcript variant X8
myb-like protein X, transcript variant X10
myb-like protein X, transcript variant X9
uncharacterized protein LOC122631259 isoform X8
queuosine salvage protein, transcript variant X2
queuosine salvage protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122631303, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122631303, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
NEDD8-conjugating enzyme UBE2F-like, transcript variant X2
NEDD8-conjugating enzyme UBE2F-like, transcript variant X1
vacuolar protein-sorting-associated protein 25, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
vacuolar protein-sorting-associated protein 25, transcript variant X3
vacuolar protein-sorting-associated protein 25, transcript variant X1
vacuolar protein-sorting-associated protein 25 isoform X2
vacuolar protein-sorting-associated protein 25 isoform X1
excitatory amino acid transporter 1, transcript variant X1
excitatory amino acid transporter 1, transcript variant X2
cyclin-dependent kinases regulatory subunit
protein PRRC1-B-like, transcript variant X2
protein PRRC1-B-like, transcript variant X1
DDB1- and CUL4-associated factor 6-like, transcript variant X1
DDB1- and CUL4-associated factor 6-like, transcript variant X4
DDB1- and CUL4-associated factor 6-like, transcript variant X3
DDB1- and CUL4-associated factor 6-like, transcript variant X2
DDB1- and CUL4-associated factor 6-like isoform X1
DDB1- and CUL4-associated factor 6-like isoform X2
DDB1- and CUL4-associated factor 6-like isoform X3
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X1
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X2
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X3
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X4
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X8
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X7
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X5
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X9
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X12
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X10
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X11
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X13
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X13
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X8
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X12
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X10
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X2
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X7
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X11
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X9
calcium/calmodulin-dependent protein kinase type II delta chain isoform X5
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X4
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X3
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X1
calcium/calmodulin-dependent protein kinase type II alpha chain, transcript variant X6
calcium/calmodulin-dependent protein kinase type II alpha chain isoform X6
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X4
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X5
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X6
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X5
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X4
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X6
growth arrest-specific protein 2-like, transcript variant X2
growth arrest-specific protein 2-like isoform X2
growth arrest-specific protein 2-like, transcript variant X1
growth arrest-specific protein 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X3
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X3
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X1
interference hedgehog-like, transcript variant X1
interference hedgehog-like, transcript variant X4
interference hedgehog-like, transcript variant X2
interference hedgehog-like, transcript variant X3
interference hedgehog-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
forkhead box protein N3-like, transcript variant X1
forkhead box protein N3-like, transcript variant X2
forkhead box protein N3-like, transcript variant X3
forkhead box protein N3-like, transcript variant X4
forkhead box protein N3-like, transcript variant X5
general transcription factor 3C polypeptide 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
general transcription factor 3C polypeptide 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
general transcription factor 3C polypeptide 2-like isoform X1
uncharacterized protein LOC122631354 isoform X2
microtubule-associated protein futsch, transcript variant X2
microtubule-associated protein futsch, transcript variant X1
microtubule-associated protein futsch, transcript variant X3
microtubule-associated protein futsch, transcript variant X4
microtubule-associated protein futsch isoform X1
microtubule-associated protein futsch isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
spermatogenesis-associated protein 6, transcript variant X1
spermatogenesis-associated protein 6, transcript variant X2
spermatogenesis-associated protein 6 isoform X1
spermatogenesis-associated protein 6 isoform X2
MAP kinase-interacting serine/threonine-protein kinase 1-like, transcript variant X3
MAP kinase-interacting serine/threonine-protein kinase 1-like isoform X3
MAP kinase-interacting serine/threonine-protein kinase 1-like, transcript variant X1
MAP kinase-interacting serine/threonine-protein kinase 1-like isoform X1
MAP kinase-interacting serine/threonine-protein kinase 1-like, transcript variant X4
MAP kinase-interacting serine/threonine-protein kinase 1-like isoform X4
MAP kinase-interacting serine/threonine-protein kinase 1-like, transcript variant X2
MAP kinase-interacting serine/threonine-protein kinase 1-like isoform X2
MAP kinase-interacting serine/threonine-protein kinase 1-like, transcript variant X5
MAP kinase-interacting serine/threonine-protein kinase 1-like isoform X5
S-phase kinase-associated protein 2-like, transcript variant X3
S-phase kinase-associated protein 2-like, transcript variant X2
S-phase kinase-associated protein 2-like, transcript variant X5
S-phase kinase-associated protein 2-like, transcript variant X1
S-phase kinase-associated protein 2-like isoform X1
S-phase kinase-associated protein 2-like isoform X2
S-phase kinase-associated protein 2-like, transcript variant X4
S-phase kinase-associated protein 2-like isoform X3
S-phase kinase-associated protein 2-like
uncharacterized LOC122631322, transcript variant X1
uncharacterized LOC122631322, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
myosin regulatory light chain sqh, transcript variant X2
myosin regulatory light chain sqh, transcript variant X1
myosin regulatory light chain sqh isoform X2
myosin regulatory light chain sqh isoform X1
myosin regulatory light chain sqh, transcript variant X3
myosin regulatory light chain sqh isoform X3
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 isoform X2
uncharacterized LOC122631316, transcript variant X1
uncharacterized LOC122631316, transcript variant X2
uncharacterized protein LOC122631316 isoform X1
uncharacterized protein LOC122631316 isoform X2
twisted gastrulation protein homolog 1-A-like, transcript variant X4
twisted gastrulation protein homolog 1-A-like, transcript variant X5
twisted gastrulation protein homolog 1-A-like, transcript variant X1
twisted gastrulation protein homolog 1-A-like, transcript variant X2
twisted gastrulation protein homolog 1-A-like, transcript variant X3
twisted gastrulation protein homolog 1-A-like, transcript variant X6
twisted gastrulation protein homolog 1-A-like isoform X3
twisted gastrulation protein homolog 1-A-like isoform X1
twisted gastrulation protein homolog 1-A-like isoform X2
aminopeptidase N-like, transcript variant X2
aminopeptidase N-like, transcript variant X1
acetylcholine receptor subunit alpha-like, transcript variant X3
acetylcholine receptor subunit alpha-like, transcript variant X2
acetylcholine receptor subunit alpha-like, transcript variant X4
acetylcholine receptor subunit alpha-like, transcript variant X1
acetylcholine receptor subunit alpha-like, transcript variant X5
acetylcholine receptor subunit alpha-like isoform X1
acetylcholine receptor subunit alpha-like isoform X2
acetylcholine receptor subunit alpha-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TWiK family of potassium channels protein 18-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
odorant receptor 67c-like, transcript variant X1
odorant receptor 67c-like, transcript variant X2
thyrotropin-releasing hormone-degrading ectoenzyme-like, transcript variant X1
thyrotropin-releasing hormone-degrading ectoenzyme-like, transcript variant X2
thyrotropin-releasing hormone-degrading ectoenzyme-like
tachykinin-like peptides receptor 86C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tachykinin-like peptides receptor 86C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tachykinin-like peptides receptor 86C, transcript variant X1
tachykinin-like peptides receptor 86C isoform X3
tachykinin-like peptides receptor 86C isoform X2
tachykinin-like peptides receptor 86C isoform X1
tachykinin-like peptides receptor 86C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
MKI67 FHA domain-interacting nucleolar phosphoprotein-like
tachykinin-like peptides receptor 86C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tachykinin-like peptides receptor 86C isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
28S ribosomal protein S24, mitochondrial
CCR4-NOT transcription complex subunit 6-like, transcript variant X3
CCR4-NOT transcription complex subunit 6-like, transcript variant X7
CCR4-NOT transcription complex subunit 6-like, transcript variant X4
CCR4-NOT transcription complex subunit 6-like, transcript variant X2
CCR4-NOT transcription complex subunit 6-like, transcript variant X1
CCR4-NOT transcription complex subunit 6-like, transcript variant X6
CCR4-NOT transcription complex subunit 6-like, transcript variant X5
CCR4-NOT transcription complex subunit 6-like isoform X2
CCR4-NOT transcription complex subunit 6-like isoform X1
CCR4-NOT transcription complex subunit 6-like isoform X3
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122631098, transcript variant X2
uncharacterized protein LOC122631098 isoform X2
uncharacterized LOC122631098, transcript variant X1
uncharacterized protein LOC122631098 isoform X1
probable serine/threonine-protein kinase DDB_G0267686, transcript variant X3
probable serine/threonine-protein kinase DDB_G0267686, transcript variant X2
probable serine/threonine-protein kinase DDB_G0267686, transcript variant X4
probable serine/threonine-protein kinase DDB_G0267686, transcript variant X1
probable serine/threonine-protein kinase DDB_G0267686 isoform X2
probable serine/threonine-protein kinase DDB_G0267686 isoform X1
storkhead-box protein 2, transcript variant X2
storkhead-box protein 2, transcript variant X1
storkhead-box protein 2, transcript variant X3
spermine synthase, transcript variant X2
spermine synthase, transcript variant X1
spermine synthase, transcript variant X4
spermine synthase, transcript variant X3
spermine synthase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
disco-interacting protein 2, transcript variant X3
disco-interacting protein 2, transcript variant X2
disco-interacting protein 2, transcript variant X1
disco-interacting protein 2, transcript variant X4
disco-interacting protein 2, transcript variant X6
disco-interacting protein 2, transcript variant X5
disco-interacting protein 2, transcript variant X7
disco-interacting protein 2, transcript variant X10
disco-interacting protein 2, transcript variant X9
disco-interacting protein 2, transcript variant X8
disco-interacting protein 2 homolog A isoform X7
disco-interacting protein 2 homolog A isoform X1
disco-interacting protein 2 homolog A isoform X3
disco-interacting protein 2 homolog A isoform X2
disco-interacting protein 2 homolog A isoform X4
disco-interacting protein 2 homolog A isoform X6
uncharacterized LOC122631102, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122631102, transcript variant X3
uncharacterized LOC122631102, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
anion exchange protein 2, transcript variant X7
anion exchange protein 2, transcript variant X3
anion exchange protein 2, transcript variant X4
anion exchange protein 2, transcript variant X5
anion exchange protein 2, transcript variant X6
anion exchange protein 2, transcript variant X1
anion exchange protein 2, transcript variant X2
anion exchange protein 2, transcript variant X8
band 3 anion transport protein isoform X5
anion exchange protein 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
U6 snRNA-associated Sm-like protein LSm5
myosin-2 heavy chain-like, transcript variant X3
myosin-2 heavy chain-like, transcript variant X1
myosin-2 heavy chain-like, transcript variant X2
uncharacterized protein LOC122630877 isoform X1
uncharacterized protein LOC122630877 isoform X2
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog, transcript variant X1
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog, transcript variant X2
lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, transcript variant X2
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X2
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, transcript variant X1
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X1
juvenile hormone epoxide hydrolase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
juvenile hormone epoxide hydrolase 2-like
thyrotroph embryonic factor, transcript variant X3
thyrotroph embryonic factor, transcript variant X4
thyrotroph embryonic factor, transcript variant X1
thyrotroph embryonic factor, transcript variant X2
thyrotroph embryonic factor, transcript variant X7
thyrotroph embryonic factor, transcript variant X5
thyrotroph embryonic factor, transcript variant X6
thyrotroph embryonic factor, transcript variant X9
thyrotroph embryonic factor, transcript variant X8
protamine-like protein, transcript variant X1
protamine-like protein, transcript variant X2
protamine-like protein, transcript variant X3
histone-lysine N-methyltransferase set1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
histone-lysine N-methyltransferase set1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
histone-lysine N-methyltransferase set1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
histone-lysine N-methyltransferase set1 isoform X2
histone-lysine N-methyltransferase set1 isoform X1
breast cancer type 2 susceptibility protein homolog, transcript variant X1
breast cancer type 2 susceptibility protein homolog, transcript variant X2
breast cancer type 2 susceptibility protein homolog isoform X1
breast cancer type 2 susceptibility protein homolog isoform X2
DNA-directed RNA polymerase I subunit RPA43
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator-like protein 1, transcript variant X3
aryl hydrocarbon receptor nuclear translocator-like protein 1, transcript variant X2
aryl hydrocarbon receptor nuclear translocator-like protein 1, transcript variant X1
aryl hydrocarbon receptor nuclear translocator-like protein 1, transcript variant X5
aryl hydrocarbon receptor nuclear translocator-like protein 1 isoform X2
aryl hydrocarbon receptor nuclear translocator-like protein 1 isoform X1
aryl hydrocarbon receptor nuclear translocator-like protein 1 isoform X3
aryl hydrocarbon receptor nuclear translocator-like protein 1 isoform X5
aryl hydrocarbon receptor nuclear translocator-like protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator-like protein 1 isoform X4
plasma membrane ascorbate-dependent reductase CYBRD1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
plasma membrane ascorbate-dependent reductase CYBRD1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
plasma membrane ascorbate-dependent reductase CYBRD1-like isoform X1
plasma membrane ascorbate-dependent reductase CYBRD1-like isoform X2
BRCA2-interacting transcriptional repressor EMSY, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
BRCA2-interacting transcriptional repressor EMSY, transcript variant X5
BRCA2-interacting transcriptional repressor EMSY, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
BRCA2-interacting transcriptional repressor EMSY, transcript variant X4
BRCA2-interacting transcriptional repressor EMSY, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
BRCA2-interacting transcriptional repressor EMSY, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
BRCA2-interacting transcriptional repressor EMSY, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
BRCA2-interacting transcriptional repressor EMSY isoform X1
BRCA2-interacting transcriptional repressor EMSY isoform X4
BRCA2-interacting transcriptional repressor EMSY isoform X3
BRCA2-interacting transcriptional repressor EMSY isoform X5
BRCA2-interacting transcriptional repressor EMSY isoform X2
BRCA2-interacting transcriptional repressor EMSY isoform X6
BRCA2-interacting transcriptional repressor EMSY isoform X7
small nuclear ribonucleoprotein-associated protein B, transcript variant X2
small nuclear ribonucleoprotein-associated protein B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
small nuclear ribonucleoprotein-associated protein B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cuticle protein 16.5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cuticle protein 16.5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cuticle protein 16.5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
vitelline membrane protein Vm26Ab-like isoform X2
predicted GPI-anchored protein 58 isoform X1
intraflagellar transport protein 81 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
intraflagellar transport protein 81 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
intraflagellar transport protein 81 homolog isoform X1
intraflagellar transport protein 81 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
glyoxylate reductase/hydroxypyruvate reductase-like, transcript variant X1
glyoxylate reductase/hydroxypyruvate reductase-like, transcript variant X3
glyoxylate reductase/hydroxypyruvate reductase-like, transcript variant X2
glyoxylate reductase/hydroxypyruvate reductase-like isoform X1
glyoxylate reductase/hydroxypyruvate reductase-like isoform X2
phosphatidate phosphatase LPIN3, transcript variant X5
phosphatidate phosphatase LPIN3, transcript variant X4
phosphatidate phosphatase LPIN3, transcript variant X6
phosphatidate phosphatase LPIN3, transcript variant X3
phosphatidate phosphatase LPIN3, transcript variant X1
phosphatidate phosphatase LPIN3, transcript variant X2
phosphatidate phosphatase LPIN3 isoform X1
phosphatidate phosphatase LPIN3 isoform X2
phosphatidate phosphatase LPIN2 isoform X5
phosphatidate phosphatase LPIN3 isoform X4
phosphatidate phosphatase LPIN3 isoform X3
14-3-3 protein zeta, transcript variant X6
14-3-3 protein zeta, transcript variant X3
14-3-3 protein zeta, transcript variant X5
14-3-3 protein zeta, transcript variant X4
14-3-3 protein zeta, transcript variant X7
14-3-3 protein zeta, transcript variant X1
14-3-3 protein zeta, transcript variant X2
ATP-dependent 6-phosphofructokinase, transcript variant X2
ATP-dependent 6-phosphofructokinase, transcript variant X1
ATP-dependent 6-phosphofructokinase, transcript variant X6
ATP-dependent 6-phosphofructokinase, transcript variant X7
ATP-dependent 6-phosphofructokinase, transcript variant X8
ATP-dependent 6-phosphofructokinase, transcript variant X9
ATP-dependent 6-phosphofructokinase, transcript variant X10
ATP-dependent 6-phosphofructokinase, transcript variant X3
ATP-dependent 6-phosphofructokinase, transcript variant X4
ATP-dependent 6-phosphofructokinase, transcript variant X5
ATP-dependent 6-phosphofructokinase isoform X1
ATP-dependent 6-phosphofructokinase isoform X3
ATP-dependent 6-phosphofructokinase isoform X4
ATP-dependent 6-phosphofructokinase isoform X5
ATP-dependent 6-phosphofructokinase isoform X2
ATP-dependent 6-phosphofructokinase isoform X6
uncharacterized LOC122631007, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC122631007, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein LOC122631007 isoform X1
uncharacterized protein LOC122631007 isoform X2
5-hydroxytryptamine receptor 2A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
5-hydroxytryptamine receptor 2A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ras-related protein Rab6, transcript variant X4
ras-related protein Rab6, transcript variant X1
ras-related protein Rab6, transcript variant X2
ras-related protein Rab6, transcript variant X3
neuroligin-4, Y-linked, transcript variant X2
neuroligin-4, Y-linked, transcript variant X1
neuroligin-4, Y-linked, transcript variant X3
uncharacterized LOC122630924, transcript variant X2
uncharacterized LOC122630924, transcript variant X1
uncharacterized protein LOC122630924 isoform X1
uncharacterized LOC122630924, transcript variant X3
uncharacterized LOC122630924, transcript variant X4
uncharacterized protein LOC122630924 isoform X3
uncharacterized protein LOC122630924 isoform X2
uncharacterized protein LOC122630924 isoform X4
uncharacterized LOC122631391, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC122631391, transcript variant X4
uncharacterized LOC122631391, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC122631391, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
protein arginine N-methyltransferase 9-like, transcript variant X8
protein arginine N-methyltransferase 9-like, transcript variant X9
protein arginine N-methyltransferase 9-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein arginine N-methyltransferase 9-like, transcript variant X6
protein arginine N-methyltransferase 9-like, transcript variant X5
protein arginine N-methyltransferase 9-like, transcript variant X2
protein arginine N-methyltransferase 9-like, transcript variant X1
protein arginine N-methyltransferase 9-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC122630889 isoform X4
protein arginine N-methyltransferase 9-like isoform X1
protein arginine N-methyltransferase 9-like isoform X3
protein arginine N-methyltransferase 9-like isoform X5
protein arginine N-methyltransferase 9-like, transcript variant X3
protein arginine N-methyltransferase 9-like isoform X2
protein arginine N-methyltransferase 9-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
protein arginine N-methyltransferase 9-like isoform X6
succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
methyltransferase-like protein 17, mitochondrial, transcript variant X1
methyltransferase-like protein 17, mitochondrial, transcript variant X2
methyltransferase-like protein 17, mitochondrial, transcript variant X3
methyltransferase-like protein 17, mitochondrial
uncharacterized LOC122630970, transcript variant X2
uncharacterized LOC122630970, transcript variant X1
uncharacterized protein LOC122630970 isoform X2
uncharacterized protein LOC122630970 isoform X1
phosphorylated adapter RNA export protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
exosome complex exonuclease RRP42, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
exosome complex exonuclease RRP42, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
exosome complex exonuclease RRP42, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase
uncharacterized LOC122631073, transcript variant X6
uncharacterized LOC122631073, transcript variant X4
uncharacterized LOC122631073, transcript variant X5
uncharacterized LOC122631073, transcript variant X3
uncharacterized LOC122631073, transcript variant X2
uncharacterized LOC122631073, transcript variant X1
uncharacterized protein LOC122631073 isoform X5
uncharacterized protein LOC122631073 isoform X4
uncharacterized protein LOC122631073 isoform X3
uncharacterized protein LOC122631073 isoform X2
uncharacterized protein LOC122631073 isoform X1
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
integrator complex subunit 11, transcript variant X2
integrator complex subunit 11, transcript variant X1
integrator complex subunit 11 isoform X1
integrator complex subunit 11, transcript variant X3
integrator complex subunit 11, transcript variant X4
integrator complex subunit 11 isoform X2
integrator complex subunit 11 isoform X3
early endosome antigen 1-like, transcript variant X1
early endosome antigen 1-like, transcript variant X4
early endosome antigen 1-like, transcript variant X2
early endosome antigen 1-like, transcript variant X3
early endosome antigen 1-like, transcript variant X5
early endosome antigen 1-like, transcript variant X6
early endosome antigen 1-like isoform X3
osteoclast-stimulating factor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
osteoclast-stimulating factor 1-like, transcript variant X2
osteoclast-stimulating factor 1-like isoform X1
osteoclast-stimulating factor 1-like isoform X2
gamma-tubulin complex component 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
gamma-tubulin complex component 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
gamma-tubulin complex component 4 isoform X2
gamma-tubulin complex component 4 isoform X1
GATA zinc finger domain-containing protein 10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
GATA zinc finger domain-containing protein 10-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
GATA zinc finger domain-containing protein 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
GATA zinc finger domain-containing protein 10-like isoform X1
GATA zinc finger domain-containing protein 10-like isoform X2
GATA zinc finger domain-containing protein 10-like isoform X3
uncharacterized LOC122630969, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122630969, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC122630969, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 300-like, transcript variant X3
zinc finger protein 300-like, transcript variant X2
zinc finger protein 300-like, transcript variant X1
enolase-phosphatase E1, transcript variant X2
enolase-phosphatase E1, transcript variant X1
zinc finger protein 814-like, transcript variant X2
zinc finger protein 814-like, transcript variant X1
cytochrome c oxidase subunit 5A, mitochondrial
DNA-binding protein P3A2, transcript variant X2
DNA-binding protein P3A2, transcript variant X4
DNA-binding protein P3A2, transcript variant X5
DNA-binding protein P3A2, transcript variant X1
DNA-binding protein P3A2, transcript variant X3
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X6
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X4
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X2
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X1
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X3
5-demethoxyubiquinone hydroxylase, mitochondrial isoform X1
5-demethoxyubiquinone hydroxylase, mitochondrial, transcript variant X5
5-demethoxyubiquinone hydroxylase, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
scm-like with four MBT domains protein 2, transcript variant X2
scm-like with four MBT domains protein 2, transcript variant X4
scm-like with four MBT domains protein 2, transcript variant X3
scm-like with four MBT domains protein 2, transcript variant X1
scm-like with four MBT domains protein 2 isoform X2
scm-like with four MBT domains protein 2 isoform X4
scm-like with four MBT domains protein 2 isoform X3
scm-like with four MBT domains protein 2 isoform X1
peptide chain release factor 1-like, mitochondrial
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X4
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X4
protein rolling stone-like, transcript variant X2
voltage-dependent calcium channel subunit alpha-2/delta-3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
voltage-dependent calcium channel subunit alpha-2/delta-4 isoform X5
protein rolling stone-like, transcript variant X1
protein rolling stone-like, transcript variant X4
protein rolling stone-like, transcript variant X5
protein rolling stone-like, transcript variant X3
zinc finger and BTB domain-containing protein 17-like, transcript variant X1
zinc finger and BTB domain-containing protein 17-like, transcript variant X2
zinc finger and BTB domain-containing protein 17-like isoform X2
zinc finger and BTB domain-containing protein 17-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
F-box/WD repeat-containing protein 9-like
solute carrier family 52, riboflavin transporter, member 3-A-like, transcript variant X2
solute carrier family 52, riboflavin transporter, member 3-A-like, transcript variant X1
solute carrier family 52, riboflavin transporter, member 3-A-like
uncharacterized LOC122631137, transcript variant X1
uncharacterized LOC122631137, transcript variant X4
uncharacterized LOC122631137, transcript variant X3
uncharacterized LOC122631137, transcript variant X2
uncharacterized LOC122631137, transcript variant X5
uncharacterized LOC122631137, transcript variant X6
uncharacterized LOC122631137, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
outer dynein arm-docking complex subunit 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
uncharacterized LOC122631141, transcript variant X1
uncharacterized LOC122631141, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
bromodomain-containing protein 7, transcript variant X9
bromodomain-containing protein 7, transcript variant X8
bromodomain-containing protein 7, transcript variant X5
bromodomain-containing protein 7, transcript variant X1
bromodomain-containing protein 7, transcript variant X10
bromodomain-containing protein 7, transcript variant X6
bromodomain-containing protein 7, transcript variant X2
bromodomain-containing protein 7, transcript variant X4
bromodomain-containing protein 7, transcript variant X3
bromodomain-containing protein 7, transcript variant X7
bromodomain-containing protein 7 isoform X1
bromodomain-containing protein 7 isoform X2
solute carrier family 12 member 4, transcript variant X1
solute carrier family 12 member 4, transcript variant X2
solute carrier family 12 member 4, transcript variant X3
solute carrier family 12 member 4 isoform X1
solute carrier family 12 member 4 isoform X2
solute carrier family 12 member 4 isoform X3
solute carrier family 12 member 4, transcript variant X4
solute carrier family 12 member 4 isoform X4
solute carrier family 12 member 4, transcript variant X7
solute carrier family 12 member 4 isoform X6
solute carrier family 12 member 4, transcript variant X6
solute carrier family 12 member 4, transcript variant X5
solute carrier family 12 member 4 isoform X5
NGFI-A-binding protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
NGFI-A-binding protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
NGFI-A-binding protein homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NGFI-A-binding protein homolog isoform X2
NGFI-A-binding protein homolog isoform X1
NGFI-A-binding protein homolog isoform X3
NGFI-A-binding protein homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
NGFI-A-binding protein homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
dnaJ homolog subfamily C member 16, transcript variant X1
dnaJ homolog subfamily C member 16, transcript variant X2
dnaJ homolog subfamily C member 16 isoform X1
dnaJ homolog subfamily C member 16 isoform X2
dnaJ homolog subfamily C member 16, transcript variant X3
dnaJ homolog subfamily C member 16, transcript variant X4
dnaJ homolog subfamily C member 16 isoform X3
dnaJ homolog subfamily C member 16 isoform X4
MICOS complex subunit Mic10-like, transcript variant X2
MICOS complex subunit Mic10-like, transcript variant X1
sugar transporter SWEET1, transcript variant X2
sugar transporter SWEET1, transcript variant X1
aryl hydrocarbon receptor protein 1, transcript variant X1
aryl hydrocarbon receptor protein 1, transcript variant X2
aryl hydrocarbon receptor protein 1 isoform X2
aryl hydrocarbon receptor protein 1 isoform X1
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
nucleoside-triphosphatase THEP1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
nucleoside-triphosphatase THEP1, transcript variant X1
nucleoside-triphosphatase THEP1 isoform X2
nucleoside-triphosphatase THEP1 isoform X1
serine/threonine-protein phosphatase 5, transcript variant X1
serine/threonine-protein phosphatase 5, transcript variant X2
uncharacterized LOC122631227, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122631227, transcript variant X1
uncharacterized LOC122631227, transcript variant X3
uncharacterized protein DDB_G0284459, transcript variant X2
uncharacterized protein DDB_G0284459, transcript variant X1
uncharacterized protein DDB_G0284459 isoform X2
uncharacterized protein DDB_G0284459 isoform X1
uncharacterized protein DDB_G0284459, transcript variant X3
uncharacterized protein LOC122630947 isoform X3
sterol carrier protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
sterol carrier protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
sterol carrier protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
dopamine receptor 1, transcript variant X1
dopamine receptor 1, transcript variant X3
dopamine receptor 1, transcript variant X5
dopamine receptor 1, transcript variant X2
dopamine receptor 1, transcript variant X4
dopamine receptor 1, transcript variant X6
uncharacterized LOC122631215, transcript variant X2
uncharacterized LOC122631215, transcript variant X1
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X2
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X3
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X1
meiosis-specific coiled-coil domain-containing protein MEIOC-like isoform X2
meiosis-specific coiled-coil domain-containing protein MEIOC-like isoform X1
meiosis-specific coiled-coil domain-containing protein MEIOC-like isoform X3
meiosis-specific coiled-coil domain-containing protein MEIOC-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
casein kinase II subunit alpha, transcript variant X2
casein kinase II subunit alpha, transcript variant X5
casein kinase II subunit alpha, transcript variant X3
casein kinase II subunit alpha, transcript variant X1
casein kinase II subunit alpha, transcript variant X6
casein kinase II subunit alpha, transcript variant X4
casein kinase II subunit alpha isoform X2
casein kinase II subunit alpha isoform X1
transmembrane protein 64, transcript variant X2
transmembrane protein 64, transcript variant X1
translational activator of cytochrome c oxidase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
exosome complex component RRP45, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
exosome complex component RRP45, transcript variant X2
exosome complex component RRP45, transcript variant X3
exosome complex component RRP45 isoform X1
exosome complex component RRP45 isoform X2
exosome complex component RRP45 isoform X3
histone deacetylase complex subunit SAP30 homolog, transcript variant X2
histone deacetylase complex subunit SAP30 homolog, transcript variant X1
histone deacetylase complex subunit SAP30 homolog isoform X1
histone deacetylase complex subunit SAP30 homolog isoform X2
putative uncharacterized protein DDB_G0282133, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
putative uncharacterized protein DDB_G0282133, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
putative uncharacterized protein DDB_G0282133
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
leucine-rich repeat protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
leucine-rich repeat protein 1, transcript variant X3
leucine-rich repeat protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
leucine-rich repeat protein 1 isoform X2
leucine-rich repeat protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cytokine-inducible SH2-containing protein-like
cytochrome c oxidase assembly protein COX16 homolog, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
blastoderm-specific protein 25D, transcript variant X1
blastoderm-specific protein 25D, transcript variant X2
neuronal PAS domain-containing protein 4, transcript variant X1
neuronal PAS domain-containing protein 4, transcript variant X2
neuronal PAS domain-containing protein 4, transcript variant X3
neuronal PAS domain-containing protein 4, transcript variant X5
neuronal PAS domain-containing protein 4 isoform X1
neuronal PAS domain-containing protein 4 isoform X2
neuronal PAS domain-containing protein 4, transcript variant X4
neuronal PAS domain-containing protein 4A isoform X3
neuronal PAS domain-containing protein 4A isoform X4
muscarinic acetylcholine receptor DM1, transcript variant X5
muscarinic acetylcholine receptor DM1, transcript variant X3
muscarinic acetylcholine receptor DM1, transcript variant X4
muscarinic acetylcholine receptor DM1, transcript variant X1
muscarinic acetylcholine receptor DM1, transcript variant X2
muscarinic acetylcholine receptor DM1 isoform X4
muscarinic acetylcholine receptor DM1 isoform X2
muscarinic acetylcholine receptor DM1 isoform X3
muscarinic acetylcholine receptor DM1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
activator of 90 kDa heat shock protein ATPase homolog 1, transcript variant X1
activator of 90 kDa heat shock protein ATPase homolog 1, transcript variant X2
activator of 90 kDa heat shock protein ATPase homolog 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: glutamate-gated chloride channel-like
uncharacterized LOC122631011, transcript variant X2
uncharacterized LOC122631011, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ionotropic receptor 75a-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ionotropic receptor 75a-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X8
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X5
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X1
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X6
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X4
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X7
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X3
aldehyde dehydrogenase, dimeric NADP-preferring, transcript variant X2
aldehyde dehydrogenase, dimeric NADP-preferring isoform X6
aldehyde dehydrogenase, dimeric NADP-preferring isoform X1
aldehyde dehydrogenase, dimeric NADP-preferring isoform X2
aldehyde dehydrogenase, dimeric NADP-preferring isoform X4
aldehyde dehydrogenase, dimeric NADP-preferring isoform X3
aldehyde dehydrogenase, dimeric NADP-preferring isoform X5
uncharacterized LOC122630860, transcript variant X2
uncharacterized LOC122630860, transcript variant X1
protein naked cuticle-like, transcript variant X1
protein naked cuticle-like, transcript variant X2
AF4/FMR2 family member lilli-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
PHD finger protein rhinoceros-like isoform X2
AF4/FMR2 family member lilli-like, transcript variant X1
AF4/FMR2 family member lilli-like isoform X1
AF4/FMR2 family member lilli-like, transcript variant X3
PHD finger protein rhinoceros-like isoform X3
mediator of RNA polymerase II transcription subunit 29, transcript variant X4
mediator of RNA polymerase II transcription subunit 29, transcript variant X1
mediator of RNA polymerase II transcription subunit 29, transcript variant X3
mediator of RNA polymerase II transcription subunit 29, transcript variant X2
mediator of RNA polymerase II transcription subunit 29 isoform X1
mediator of RNA polymerase II transcription subunit 29 isoform X2
serum response factor homolog, transcript variant X1
serum response factor homolog, transcript variant X2
electron transfer flavoprotein subunit beta, transcript variant X1
electron transfer flavoprotein subunit beta, transcript variant X3
electron transfer flavoprotein subunit beta, transcript variant X2
electron transfer flavoprotein subunit beta isoform X1
electron transfer flavoprotein subunit beta isoform X2
CDC42 small effector protein homolog, transcript variant X1
CDC42 small effector protein homolog, transcript variant X2
dnaJ homolog subfamily C member 7, transcript variant X1
dnaJ homolog subfamily C member 7, transcript variant X2
uncharacterized LOC122631187, transcript variant X1
uncharacterized LOC122631187, transcript variant X2
uncharacterized protein LOC122631187 isoform X1
uncharacterized protein LOC122631187 isoform X2
uncharacterized LOC122631188, transcript variant X1
uncharacterized LOC122631188, transcript variant X2
uncharacterized protein LOC122631188 isoform X1
uncharacterized protein LOC122631188 isoform X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial, transcript variant X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial, transcript variant X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial isoform X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial isoform X2
trithorax group protein osa, transcript variant X2
trithorax group protein osa, transcript variant X1
trithorax group protein osa, transcript variant X3
trithorax group protein osa, transcript variant X7
trithorax group protein osa, transcript variant X5
trithorax group protein osa, transcript variant X4
trithorax group protein osa, transcript variant X6
vacuolar protein sorting-associated protein 13C-like, transcript variant X2
vacuolar protein sorting-associated protein 13C-like, transcript variant X1
vacuolar protein sorting-associated protein 13C-like, transcript variant X5
vacuolar protein sorting-associated protein 13C-like isoform X2
vacuolar protein sorting-associated protein 13C-like isoform X1
vacuolar protein sorting-associated protein 13C-like isoform X4
vacuolar protein sorting-associated protein 13C-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13C-like, transcript variant X4
vacuolar protein sorting-associated protein 13C-like isoform X3
uncharacterized LOC122630975, transcript variant X3
uncharacterized LOC122630975, transcript variant X2
uncharacterized LOC122630975, transcript variant X4
uncharacterized LOC122630975, transcript variant X12
uncharacterized LOC122630975, transcript variant X11
uncharacterized LOC122630975, transcript variant X1
uncharacterized LOC122630975, transcript variant X5
uncharacterized LOC122630975, transcript variant X7
uncharacterized LOC122630975, transcript variant X10
uncharacterized LOC122630975, transcript variant X6
uncharacterized LOC122630975, transcript variant X9
uncharacterized LOC122630975, transcript variant X8
uncharacterized protein LOC122630975 isoform X3
uncharacterized protein LOC122630975 isoform X6
uncharacterized protein LOC122630975 isoform X5
uncharacterized protein LOC122630975 isoform X1
uncharacterized protein LOC122630975 isoform X2
uncharacterized protein LOC122630975 isoform X4
iduronate 2-sulfatase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
iduronate 2-sulfatase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
iduronate 2-sulfatase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
iduronate 2-sulfatase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
iduronate 2-sulfatase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
BRISC and BRCA1-A complex member 2-like, transcript variant X1
BRISC and BRCA1-A complex member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 4, transcript variant X3
mediator of RNA polymerase II transcription subunit 4, transcript variant X2
mediator of RNA polymerase II transcription subunit 4, transcript variant X4
mediator of RNA polymerase II transcription subunit 4, transcript variant X1
mediator of RNA polymerase II transcription subunit 4 isoform X2
mediator of RNA polymerase II transcription subunit 4 isoform X1
DNA replication complex GINS protein PSF1-like, transcript variant X2
DNA replication complex GINS protein PSF1-like, transcript variant X1
DNA replication complex GINS protein PSF1-like isoform X1
DNA replication complex GINS protein PSF1-like isoform X2
uncharacterized LOC122631025, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC122631025, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC122631025 isoform X1
uncharacterized protein LOC122631025 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
ATPase family protein 2 homolog, transcript variant X5
ATPase family protein 2 homolog, transcript variant X3
ATPase family protein 2 homolog, transcript variant X6
ATPase family protein 2 homolog, transcript variant X4
ATPase family protein 2 homolog, transcript variant X1
ATPase family protein 2 homolog, transcript variant X2
DBF4-type zinc finger-containing protein 2 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
uncharacterized LOC122631081, transcript variant X1
uncharacterized LOC122631081, transcript variant X2
bone morphogenetic protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
bone morphogenetic protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
bone morphogenetic protein 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
bone morphogenetic protein 4-like isoform X1
bone morphogenetic protein 2-like isoform X2
uncharacterized LOC122631052, transcript variant X2
uncharacterized LOC122631052, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
intraflagellar transport protein 43 homolog, transcript variant X1
intraflagellar transport protein 43 homolog, transcript variant X2
intraflagellar transport protein 43 homolog isoform X1
intraflagellar transport protein 43 homolog isoform X2
mitochondrial import receptor subunit TOM40 homolog 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
endoplasmic reticulum lectin 1, transcript variant X2
endoplasmic reticulum lectin 1, transcript variant X1
endoplasmic reticulum lectin 1 isoform X2
endoplasmic reticulum lectin 1 isoform X1
myb-like protein I, transcript variant X1
myb-like protein I, transcript variant X2
orexin receptor type 1-like, transcript variant X8
orexin receptor type 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
orexin receptor type 1-like, transcript variant X4
orexin receptor type 1-like, transcript variant X6
orexin receptor type 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
orexin receptor type 1-like, transcript variant X3
orexin receptor type 1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
orexin receptor type 1-like, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
protein croquemort, transcript variant X3
protein croquemort, transcript variant X1
protein croquemort, transcript variant X2
intraflagellar transport protein 57 homolog, transcript variant X1
intraflagellar transport protein 57 homolog, transcript variant X3
intraflagellar transport protein 57 homolog, transcript variant X2
intraflagellar transport protein 57 homolog isoform X1
intraflagellar transport protein 57 homolog isoform X2
intraflagellar transport protein 57 homolog isoform X3
uncharacterized LOC122630964, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122630964, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122630964, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC122630964 isoform X1
uncharacterized LOC122630964, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC122630964 isoform X2
peptidyl-prolyl cis-trans isomerase NIMA-interacting 4
mitochondrial intermediate peptidase, transcript variant X3
mitochondrial intermediate peptidase, transcript variant X4
mitochondrial intermediate peptidase, transcript variant X1
mitochondrial intermediate peptidase, transcript variant X2
histone deacetylase 6, transcript variant X4
histone deacetylase 6, transcript variant X1
histone deacetylase 6, transcript variant X2
histone deacetylase 6, transcript variant X3
histone deacetylase 6, transcript variant X5
delta(14)-sterol reductase TM7SF2, transcript variant X1
delta(14)-sterol reductase TM7SF2, transcript variant X2
delta(14)-sterol reductase TM7SF2 isoform X1
delta(14)-sterol reductase TM7SF2 isoform X2
heat shock factor 2-binding protein-like
monocarboxylate transporter 3, transcript variant X5
monocarboxylate transporter 3, transcript variant X1
monocarboxylate transporter 3, transcript variant X2
monocarboxylate transporter 3 isoform X1
monocarboxylate transporter 3 isoform X2
monocarboxylate transporter 12 isoform X5
uncharacterized LOC122630968, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC122630968, transcript variant X4
uncharacterized LOC122630968, transcript variant X5
uncharacterized LOC122630968, transcript variant X3
uncharacterized LOC122630968, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC122630968, transcript variant X2
uncharacterized LOC122630968, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC122630968, transcript variant X8
monocarboxylate transporter 3, transcript variant X4
monocarboxylate transporter 3 isoform X4
monocarboxylate transporter 3, transcript variant X3
monocarboxylate transporter 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC122631055, transcript variant X3
uncharacterized LOC122631055, transcript variant X5
uncharacterized LOC122631055, transcript variant X4
uncharacterized protein LOC122631055 isoform X3
uncharacterized LOC122631055, transcript variant X8
uncharacterized LOC122631055, transcript variant X6
uncharacterized LOC122631055, transcript variant X7
uncharacterized LOC122631055, transcript variant X1
uncharacterized LOC122631055, transcript variant X2
uncharacterized protein LOC122631055 isoform X1
uncharacterized protein LOC122631055 isoform X2
uncharacterized protein LOC122631055 isoform X4
lysM and putative peptidoglycan-binding domain-containing protein 3
uncharacterized LOC122631053, transcript variant X10
uncharacterized LOC122631053, transcript variant X11
uncharacterized LOC122631053, transcript variant X1
uncharacterized LOC122631053, transcript variant X6
uncharacterized LOC122631053, transcript variant X3
uncharacterized LOC122631053, transcript variant X5
uncharacterized LOC122631053, transcript variant X4
uncharacterized LOC122631053, transcript variant X2
uncharacterized LOC122631053, transcript variant X8
uncharacterized LOC122631053, transcript variant X7
uncharacterized LOC122631053, transcript variant X13
uncharacterized LOC122631053, transcript variant X9
uncharacterized LOC122631053, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 14, transcript variant X2
tyrosine-protein phosphatase non-receptor type 14, transcript variant X1
tyrosine-protein phosphatase non-receptor type 14 isoform X2
tyrosine-protein phosphatase non-receptor type 14 isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform
uncharacterized LOC122631063, transcript variant X1
uncharacterized LOC122631063, transcript variant X2
scaffold protein salvador-like, transcript variant X2
scaffold protein salvador-like, transcript variant X3
scaffold protein salvador-like, transcript variant X1
scaffold protein salvador-like isoform X1
scaffold protein salvador-like isoform X2
protein salvador homolog 1-like isoform X3
uncharacterized LOC122631046, transcript variant X2
uncharacterized LOC122631046, transcript variant X1
nuclear inhibitor of protein phosphatase 1, transcript variant X2
nuclear inhibitor of protein phosphatase 1, transcript variant X1
nuclear inhibitor of protein phosphatase 1 isoform X1
nuclear inhibitor of protein phosphatase 1 isoform X2
thioredoxin, mitochondrial, transcript variant X3
thioredoxin, mitochondrial, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
thioredoxin, mitochondrial, transcript variant X2
thioredoxin, mitochondrial, transcript variant X4
thioredoxin, mitochondrial, transcript variant X1
pecanex-like protein 1, transcript variant X2
pecanex-like protein 1, transcript variant X1
mitogen-activated protein kinase kinase kinase 11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 11-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 11-like isoform X1
mitogen-activated protein kinase kinase kinase 11-like isoform X3
mitogen-activated protein kinase kinase kinase 11-like isoform X2
galactose mutarotase-like, transcript variant X1
galactose mutarotase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
eukaryotic translation initiation factor 3 subunit F
26S proteasome non-ATPase regulatory subunit 8
probable 39S ribosomal protein L49, mitochondrial
centromere-associated protein E, transcript variant X2
centromere-associated protein E, transcript variant X3
centromere-associated protein E, transcript variant X1
uncharacterized LOC122631205, transcript variant X2
uncharacterized LOC122631205, transcript variant X1
uncharacterized protein LOC122631205 isoform X1
uncharacterized protein LOC122631205 isoform X2
uncharacterized LOC122631206, transcript variant X2
uncharacterized LOC122631206, transcript variant X1
uncharacterized LOC122631206, transcript variant X4
uncharacterized LOC122631206, transcript variant X3
uncharacterized LOC122631206, transcript variant X5
glutaredoxin-related protein 5, mitochondrial
potassium voltage-gated channel protein eag, transcript variant X1
potassium voltage-gated channel protein eag, transcript variant X5
potassium voltage-gated channel protein eag, transcript variant X3
potassium voltage-gated channel protein eag, transcript variant X6
potassium voltage-gated channel protein eag, transcript variant X2
potassium voltage-gated channel protein eag, transcript variant X4
potassium voltage-gated channel protein eag, transcript variant X7
potassium voltage-gated channel protein eag isoform X1
potassium voltage-gated channel protein eag isoform X5
potassium voltage-gated channel protein eag isoform X3
potassium voltage-gated channel protein eag isoform X6
potassium voltage-gated channel protein eag isoform X2
potassium voltage-gated channel protein eag isoform X4
potassium voltage-gated channel protein eag isoform X7
MTOR-associated protein MEAK7, transcript variant X4
MTOR-associated protein MEAK7, transcript variant X3
MTOR-associated protein MEAK7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
MTOR-associated protein MEAK7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
zinc finger protein 706-like, transcript variant X2
zinc finger protein 706-like, transcript variant X4
zinc finger protein 706-like, transcript variant X3
zinc finger protein 706-like, transcript variant X1
E3 ubiquitin-protein ligase hyd, transcript variant X1
E3 ubiquitin-protein ligase hyd, transcript variant X4
E3 ubiquitin-protein ligase hyd, transcript variant X2
E3 ubiquitin-protein ligase hyd, transcript variant X3
E3 ubiquitin-protein ligase UBR5 isoform X1
E3 ubiquitin-protein ligase hyd isoform X2
E3 ubiquitin-protein ligase hyd isoform X4
E3 ubiquitin-protein ligase hyd isoform X3
protein bunched, class 2/F/G isoform-like, transcript variant X2
protein bunched, class 2/F/G isoform-like, transcript variant X1
protein bunched, class 2/F/G isoform-like
RCC1-like G exchanging factor-like protein, transcript variant X1
RCC1-like G exchanging factor-like protein, transcript variant X2
RCC1-like G exchanging factor-like protein isoform X1
RCC1-like G exchanging factor-like protein isoform X2
uncharacterized LOC122631028, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC122631028, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC122631029, transcript variant X2
uncharacterized LOC122631029, transcript variant X1
uncharacterized protein LOC122631029 isoform X1
uncharacterized protein LOC122631029 isoform X2
calcium and integrin-binding protein 1-like
bestrophin-4-like, transcript variant X5
bestrophin-4-like, transcript variant X1
bestrophin-4-like, transcript variant X3
bestrophin-4-like, transcript variant X2
bestrophin-4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
RNA polymerase II-associated protein 3, transcript variant X2
RNA polymerase II-associated protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
RNA polymerase II-associated protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
mitochondrial inner membrane protease ATP23 homolog, transcript variant X1
mitochondrial inner membrane protease ATP23 homolog isoform X1
mitochondrial inner membrane protease ATP23 homolog, transcript variant X2
mitochondrial inner membrane protease ATP23 homolog isoform X2
probable 26S proteasome non-ATPase regulatory subunit 3
homeotic protein empty spiracles-like, transcript variant X1
homeotic protein empty spiracles-like, transcript variant X4
homeotic protein empty spiracles-like, transcript variant X3
homeotic protein empty spiracles-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
homeotic protein empty spiracles-like, transcript variant X2
homeotic protein empty spiracles-like isoform X1
homeotic protein empty spiracles-like isoform X2
homeotic protein empty spiracles-like isoform X5
homeotic protein empty spiracles-like isoform X3
homeotic protein empty spiracles-like isoform X4
fumarylacetoacetate hydrolase domain-containing protein 2A, transcript variant X1
fumarylacetoacetate hydrolase domain-containing protein 2A, transcript variant X2
fumarylacetoacetate hydrolase domain-containing protein 2A isoform X2
fumarylacetoacetate hydrolase domain-containing protein 2A isoform X1
39S ribosomal protein L35, mitochondrial
MICOS complex subunit Mic60, transcript variant X1
MICOS complex subunit Mic60, transcript variant X2
MICOS complex subunit Mic60, transcript variant X3
lymphocyte antigen 6D, transcript variant X2
lymphocyte antigen 6D, transcript variant X1
ubiquitin-like domain-containing CTD phosphatase 1
phosphatidylinositide phosphatase SAC2, transcript variant X1
phosphatidylinositide phosphatase SAC2, transcript variant X2
phosphatidylinositide phosphatase SAC2 isoform X1
phosphatidylinositide phosphatase SAC2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
activin receptor type-1-like, transcript variant X1
activin receptor type-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122631071, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC122631071, transcript variant X1
maternal protein exuperantia, transcript variant X5
maternal protein exuperantia, transcript variant X2
maternal protein exuperantia, transcript variant X4
maternal protein exuperantia, transcript variant X1
maternal protein exuperantia, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ethanolamine-phosphate cytidylyltransferase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
ethanolamine-phosphate cytidylyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
ethanolamine-phosphate cytidylyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
ethanolamine-phosphate cytidylyltransferase isoform X1
ethanolamine-phosphate cytidylyltransferase isoform X2
ethanolamine-phosphate cytidylyltransferase isoform X3
probable ATP-dependent RNA helicase DDX5, transcript variant X1
ATP-dependent RNA helicase dbp2 isoform X1
probable ATP-dependent RNA helicase DDX5, transcript variant X3
probable ATP-dependent RNA helicase DDX5, transcript variant X2
probable ATP-dependent RNA helicase DDX5, transcript variant X4
probable ATP-dependent RNA helicase DDX5 isoform X2
RNA-binding region-containing protein 3, transcript variant X2
RNA-binding region-containing protein 3, transcript variant X1
RNA-binding region-containing protein 3 isoform X2
RNA-binding region-containing protein 3 isoform X1
cilia- and flagella-associated protein 251-like, transcript variant X1
cilia- and flagella-associated protein 251-like isoform X1
cilia- and flagella-associated protein 251-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
RNA-binding protein 8A, transcript variant X2
RNA-binding protein 8A, transcript variant X1
F-actin-monooxygenase Mical, transcript variant X3
F-actin-monooxygenase Mical, transcript variant X8
F-actin-monooxygenase Mical, transcript variant X6
F-actin-monooxygenase Mical, transcript variant X7
F-actin-monooxygenase Mical, transcript variant X1
F-actin-monooxygenase Mical, transcript variant X2
F-actin-monooxygenase Mical, transcript variant X5
F-actin-monooxygenase Mical, transcript variant X4
F-actin-monooxygenase Mical, transcript variant X10
F-actin-monooxygenase Mical, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ras-related protein Rab-21, transcript variant X2
ras-related protein Rab-21, transcript variant X3
ras-related protein Rab-21, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
three prime repair exonuclease 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
three prime repair exonuclease 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
three prime repair exonuclease 2 isoform X1
three prime repair exonuclease 2 isoform X2
eukaryotic translation initiation factor 3 subunit J, transcript variant X1
eukaryotic translation initiation factor 3 subunit J, transcript variant X2
eukaryotic translation initiation factor 3 subunit J isoform X1
eukaryotic translation initiation factor 3 subunit J isoform X2
bifunctional glutamate/proline--tRNA ligase, transcript variant X2
bifunctional glutamate/proline--tRNA ligase, transcript variant X1
bifunctional glutamate/proline--tRNA ligase isoform X2
bifunctional glutamate/proline--tRNA ligase isoform X1
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X3
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X1
neuronal acetylcholine receptor subunit alpha-7-like isoform X1
neuronal acetylcholine receptor subunit alpha-7-like, transcript variant X2
neuronal acetylcholine receptor subunit alpha-7-like isoform X2
acetylcholine receptor subunit beta-like 1
furin-like protease 1, isoforms 1/1-X/2, transcript variant X3
furin-like protease 1, isoforms 1/1-X/2, transcript variant X1
furin-like protease 1, isoforms 1/1-X/2 isoform X3
furin-like protease 1, isoforms 1/1-X/2, transcript variant X2
dynein axonemal intermediate chain 2-like, transcript variant X1
dynein axonemal intermediate chain 2-like, transcript variant X3
dynein axonemal intermediate chain 2-like, transcript variant X2
dynein axonemal intermediate chain 2-like isoform X1
dynein axonemal intermediate chain 2-like isoform X2
uncharacterized LOC122631344, transcript variant X1
uncharacterized LOC122631344, transcript variant X3
uncharacterized LOC122631344, transcript variant X2
cyclic AMP response element-binding protein A-like, transcript variant X2
cyclic AMP response element-binding protein A-like, transcript variant X1
cyclic AMP response element-binding protein A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase RING1, transcript variant X2
E3 ubiquitin-protein ligase RING1, transcript variant X1
E3 ubiquitin-protein ligase RING1 isoform X2
E3 ubiquitin-protein ligase RING1 isoform X1
uncharacterized LOC122630849, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122630849, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122630849, transcript variant X2
uncharacterized protein LOC122630849 isoform X1
uncharacterized protein LOC122630849 isoform X2
uncharacterized protein LOC122630849 isoform X4
uncharacterized LOC122630849, transcript variant X3
uncharacterized protein LOC122630849 isoform X3
sodium-independent sulfate anion transporter-like, transcript variant X2
sodium-independent sulfate anion transporter-like, transcript variant X1
sodium-independent sulfate anion transporter-like
myb-like protein D, transcript variant X1
myb-like protein D, transcript variant X3
myb-like protein D, transcript variant X2
sodium-independent sulfate anion transporter-like isoform X1
sodium-independent sulfate anion transporter-like isoform X2
uncharacterized LOC122631118, transcript variant X2
uncharacterized LOC122631118, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hepatocyte growth factor-regulated tyrosine kinase substrate
protein CLEC16A homolog, transcript variant X3
protein CLEC16A homolog, transcript variant X1
protein CLEC16A homolog, transcript variant X4
protein CLEC16A homolog, transcript variant X2
protein CLEC16A homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
tRNA (cytosine(38)-C(5))-methyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
transcription factor MafG, transcript variant X2
transcription factor MafG, transcript variant X1
uncharacterized LOC122631385, transcript variant X2
uncharacterized LOC122631385, transcript variant X7
uncharacterized LOC122631385, transcript variant X3
uncharacterized LOC122631385, transcript variant X4
uncharacterized protein LOC122631385 isoform X2
uncharacterized protein LOC122631385 isoform X4
uncharacterized LOC122631385, transcript variant X6
uncharacterized protein LOC122631385 isoform X3
uncharacterized LOC122631385, transcript variant X1
uncharacterized LOC122631385, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized protein LOC122631385 isoform X1
prominin-like protein, transcript variant X1
prominin-like protein, transcript variant X5
prominin-like protein, transcript variant X2
prominin-like protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
prominin-like protein, transcript variant X6
prominin-like protein, transcript variant X4
prominin-like protein, transcript variant X7
intraflagellar transport protein 56, transcript variant X2
intraflagellar transport protein 56, transcript variant X1
intraflagellar transport protein 56 isoform X2
intraflagellar transport protein 56 isoform X1
cytosolic Fe-S cluster assembly factor NUBP2 homolog
uridine 5'-monophosphate synthase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uridine 5'-monophosphate synthase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uridine 5'-monophosphate synthase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uridine 5'-monophosphate synthase, transcript variant X3
uridine 5'-monophosphate synthase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ankyrin repeat and LEM domain-containing protein 2 homolog
uncharacterized LOC122631378, transcript variant X2
uncharacterized LOC122631378, transcript variant X4
uncharacterized LOC122631378, transcript variant X1
uncharacterized LOC122631378, transcript variant X3
uncharacterized protein LOC122631378 isoform X1
uncharacterized protein LOC122631378 isoform X2
beta-1,4-glucuronyltransferase 1, transcript variant X2
beta-1,4-glucuronyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC1-like, transcript variant X1
protein O-mannosyl-transferase TMTC1-like isoform X1
protein O-mannosyl-transferase TMTC1-like, transcript variant X2
protein O-mannosyl-transferase TMTC1-like isoform X2
extracellular matrix-binding protein ebh-like
uncharacterized LOC122631204, transcript variant X2
uncharacterized LOC122631204, transcript variant X1
arylalkylamine N-acetyltransferase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X2
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X3
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X1
ankyrin repeat and SAM domain-containing protein 1A-like isoform X2
uncharacterized protein LOC122631127 isoform X3
uncharacterized protein LOC122631127 isoform X1
transmembrane 7 superfamily member 3-like
paired box protein Pax-6-like, transcript variant X2
paired box protein Pax-6-like, transcript variant X3
paired box protein Pax-6-like, transcript variant X1
paired box protein Pax-6-like isoform X2
paired box protein Pax-6-like isoform X3
paired box protein Pax-6-like isoform X1
torso-like protein, transcript variant X1
torso-like protein, transcript variant X2
uncharacterized LOC122631169, transcript variant X2
uncharacterized LOC122631169, transcript variant X1
uncharacterized protein LOC122631169 isoform X1
uncharacterized protein LOC122631169 isoform X2
DNA-directed RNA polymerase I subunit RPA12, transcript variant X2
DNA-directed RNA polymerase I subunit RPA12, transcript variant X1
DNA-directed RNA polymerase I subunit RPA12
venom dipeptidyl peptidase 4, transcript variant X1
venom dipeptidyl peptidase 4, transcript variant X7
venom dipeptidyl peptidase 4, transcript variant X8
venom dipeptidyl peptidase 4, transcript variant X3
venom dipeptidyl peptidase 4, transcript variant X2
venom dipeptidyl peptidase 4, transcript variant X10
venom dipeptidyl peptidase 4, transcript variant X6
venom dipeptidyl peptidase 4, transcript variant X5
venom dipeptidyl peptidase 4, transcript variant X9
venom dipeptidyl peptidase 4, transcript variant X12
venom dipeptidyl peptidase 4, transcript variant X11
venom dipeptidyl peptidase 4, transcript variant X4
venom dipeptidyl peptidase 4, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transcription termination factor, mitochondrial, transcript variant X2
transcription termination factor, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
transcription termination factor, mitochondrial isoform X1
transcription termination factor, mitochondrial isoform X2
transcription termination factor, mitochondrial, transcript variant X3
transcription termination factor, mitochondrial isoform X3
putative ATP-dependent RNA helicase TDRD12, transcript variant X2
putative ATP-dependent RNA helicase TDRD12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
putative ATP-dependent RNA helicase TDRD12 isoform X1
putative ATP-dependent RNA helicase TDRD12 isoform X2
protein transport protein Sec23A, transcript variant X2
protein transport protein Sec23A, transcript variant X1
protein transport protein Sec23A isoform X2
protein transport protein Sec23A isoform X1
signal recognition particle subunit SRP68
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
SET and MYND domain-containing protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
poly(U)-binding-splicing factor half pint, transcript variant X2
poly(U)-binding-splicing factor half pint, transcript variant X1
poly(U)-binding-splicing factor half pint, transcript variant X3
poly(U)-binding-splicing factor half pint, transcript variant X4
poly(U)-binding-splicing factor half pint, transcript variant X5
poly(U)-binding-splicing factor half pint isoform X2
poly(U)-binding-splicing factor half pint isoform X1
poly(U)-binding-splicing factor half pint, transcript variant X6
poly(U)-binding-splicing factor half pint isoform X3
poly(U)-binding-splicing factor half pint isoform X4
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2
serine/threonine-protein kinase 10, transcript variant X8
serine/threonine-protein kinase 10, transcript variant X1
serine/threonine-protein kinase 10, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
serine/threonine-protein kinase 10, transcript variant X2
serine/threonine-protein kinase 10, transcript variant X3
serine/threonine-protein kinase 10, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
serine/threonine-protein kinase 10, transcript variant X11
serine/threonine-protein kinase 10, transcript variant X5
serine/threonine-protein kinase 10, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/threonine-protein kinase 10-A isoform X1
serine/threonine-protein kinase 10 isoform X2
serine/threonine-protein kinase 10, transcript variant X9
serine/threonine-protein kinase 10, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
flavin-containing monooxygenase FMO GS-OX-like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
flavin-containing monooxygenase FMO GS-OX-like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
flavin-containing monooxygenase FMO GS-OX-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X14
glutamate-gated chloride channel, transcript variant X18
glutamate-gated chloride channel, transcript variant X3
glutamate-gated chloride channel, transcript variant X4
glutamate-gated chloride channel, transcript variant X6
glutamate-gated chloride channel, transcript variant X7
glutamate-gated chloride channel, transcript variant X8
glutamate-gated chloride channel, transcript variant X9
glutamate-gated chloride channel, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X11
glutamate-gated chloride channel, transcript variant X2
glutamate-gated chloride channel, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X1
glutamate-gated chloride channel, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X19
glutamate-gated chloride channel, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 192 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
glutamate-gated chloride channel isoform X1
glutamate-gated chloride channel isoform X3
glutamate-gated chloride channel isoform X4
glutamate-gated chloride channel isoform X6
glutamate-gated chloride channel isoform X7
glutamate-gated chloride channel isoform X8
glutamate-gated chloride channel isoform X9
glycine receptor subunit alpha-4 isoform X10
glycine receptor subunit alpha-4 isoform X11
glutamate-gated chloride channel isoform X2
glutamate-gated chloride channel isoform X5
glutamate-gated chloride channel alpha isoform X13
glutamate-gated chloride channel isoform X12
glutamate-gated chloride channel isoform X14
glutamate-gated chloride channel isoform X15
glutamate-gated chloride channel isoform X16
glutamate-gated chloride channel isoform X18
glutamate-gated chloride channel isoform X19
glutamate-gated chloride channel isoform X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
structural maintenance of chromosomes protein 1A-like
ectonucleoside triphosphate diphosphohydrolase 5, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 5, transcript variant X3
ectonucleoside triphosphate diphosphohydrolase 5, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 5 isoform X1
ectonucleoside triphosphate diphosphohydrolase 5 isoform X3
ectonucleoside triphosphate diphosphohydrolase 5 isoform X2
mitochondrial 2-oxodicarboxylate carrier, transcript variant X4
mitochondrial 2-oxodicarboxylate carrier, transcript variant X3
mitochondrial 2-oxodicarboxylate carrier, transcript variant X2
mitochondrial 2-oxodicarboxylate carrier, transcript variant X1
mitochondrial 2-oxodicarboxylate carrier
wiskott-Aldrich syndrome protein family member 3, transcript variant X3
wiskott-Aldrich syndrome protein family member 3, transcript variant X1
wiskott-Aldrich syndrome protein family member 3, transcript variant X4
wiskott-Aldrich syndrome protein family member 3, transcript variant X6
wiskott-Aldrich syndrome protein family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
wiskott-Aldrich syndrome protein family member 3, transcript variant X5
wiskott-Aldrich syndrome protein family member 3 isoform X1
wiskott-Aldrich syndrome protein family member 3 isoform X2
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X1
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X2
ATP-binding cassette sub-family C member 4 isoform X1
probable multidrug resistance-associated protein lethal(2)03659 isoform X2
probable multidrug resistance-associated protein lethal(2)03659 isoform X3
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X4
probable multidrug resistance-associated protein lethal(2)03659 isoform X4
interleukin-1 receptor accessory protein-like 1-B, transcript variant X4
interleukin-1 receptor accessory protein-like 1-B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
interleukin-1 receptor accessory protein-like 1-B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
interleukin-1 receptor accessory protein-like 1-B, transcript variant X3
interleukin-1 receptor accessory protein-like 1-B
acetylcholinesterase-like, transcript variant X1
acetylcholinesterase-like, transcript variant X2
acetylcholinesterase-like, transcript variant X3
acetylcholinesterase-like, transcript variant X4
RCC1 and BTB domain-containing protein 1-like, transcript variant X1
RCC1 and BTB domain-containing protein 1-like, transcript variant X3
RCC1 and BTB domain-containing protein 1-like, transcript variant X2
RCC1 and BTB domain-containing protein 1-like isoform X1
RCC1 and BTB domain-containing protein 1-like isoform X2
transmembrane protein 184B, transcript variant X1
transmembrane protein 184B, transcript variant X2
transmembrane protein 184B, transcript variant X3
transmembrane protein 184B, transcript variant X4
ATP-binding cassette sub-family B member 10, mitochondrial
serine/threonine-protein phosphatase 4 regulatory subunit 2
DENN domain-containing protein 1A, transcript variant X4
DENN domain-containing protein 1A, transcript variant X3
DENN domain-containing protein 1A, transcript variant X2
DENN domain-containing protein 1A, transcript variant X1
DENN domain-containing protein 1A, transcript variant X5
DENN domain-containing protein 1A isoform X1
DENN domain-containing protein 1A isoform X5
DENN domain-containing protein 1A isoform X3
DENN domain-containing protein 1A isoform X2
DENN domain-containing protein 1A isoform X4
valine--tRNA ligase, transcript variant X2
valine--tRNA ligase, transcript variant X1
nuclear pore complex protein Nup133, transcript variant X2
nuclear pore complex protein Nup133, transcript variant X1
nuclear pore complex protein Nup133 isoform X1
nuclear pore complex protein Nup133 isoform X2